Catherine Cordonnier

Summary

Country: France

Publications

  1. ncbi request reprint Risk factors for Gram-negative bacterial infections in febrile neutropenia
    Catherine Cordonnier
    Hematology Department, Henri Mondor Hospital, 94000 Creteil, France
    Haematologica 90:1102-9. 2005
  2. pmc Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
    Catherine Cordonnier
    Service d Hematologie Clinique, Hopital Henri Mondor, 51 Av Maréchal de Lattre de Tassigny, Creteil, France
    Haematologica 95:1762-8. 2010
  3. ncbi request reprint Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia
    C Cordonnier
    Service d Hematologie Clinique, CHU Henri Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    Bone Marrow Transplant 36:649-54. 2005
  4. ncbi request reprint New findings and key questions in hematopoietic stem cell transplantation
    C Cordonnier
    Hematology Department, Henri Mondor University Hospital, 94000 Creteil, France
    Med Mycol 43:S243-6. 2005
  5. ncbi request reprint Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study
    Catherine Cordonnier
    Hopital Henri Mondor, Creteil, France
    Int J Antimicrob Agents 31:135-41. 2008
  6. ncbi request reprint [Early pneumonia after allogenic stem cell transplantation]
    C Cordonnier
    Service d Hematologie Clinique, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris et Université Paris 12, France
    Rev Mal Respir 24:523-34. 2007
  7. ncbi request reprint Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis
    C Cordonnier
    Service d Hematologie Clinique, Hopital Henri Mondor, Creteil, France
    Mycoses 50:205-9. 2007
  8. ncbi request reprint A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipients
    Catherine Cordonnier
    Departement d Hematologie, Hopital Henri Mondor, Assistance Publique Hôpitaux de Paris AP HP and Université Paris 12, Creteil, France
    Transplantation 82:86-92. 2006
  9. ncbi request reprint Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers
    Catherine Cordonnier
    Hopital Henri Mondor, AP HP and Université Paris 12, France
    Clin Infect Dis 42:955-63. 2006
  10. ncbi request reprint The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
    Catherine Cordonnier
    Hematology Department, CHU Henri Mondor, 94000 Creteil, France
    Haematologica 91:150a. 2006

Detail Information

Publications64

  1. ncbi request reprint Risk factors for Gram-negative bacterial infections in febrile neutropenia
    Catherine Cordonnier
    Hematology Department, Henri Mondor Hospital, 94000 Creteil, France
    Haematologica 90:1102-9. 2005
    ..The objective of this study was to evaluate the risk of Gram-negative bacterial infections in febrile neutropenic patients and to develop a specific risk score...
  2. pmc Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
    Catherine Cordonnier
    Service d Hematologie Clinique, Hopital Henri Mondor, 51 Av Maréchal de Lattre de Tassigny, Creteil, France
    Haematologica 95:1762-8. 2010
    ..Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the success of stem cell transplantation. Secondary prophylaxis could reduce disease burden and improve survival...
  3. ncbi request reprint Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia
    C Cordonnier
    Service d Hematologie Clinique, CHU Henri Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    Bone Marrow Transplant 36:649-54. 2005
    ..03). Finally, mean 1-year costs were not different in MA and NMA patients (P=0.75). Prospective studies comparing conventional and NMA approaches in homogeneous populations should include economic items...
  4. ncbi request reprint New findings and key questions in hematopoietic stem cell transplantation
    C Cordonnier
    Hematology Department, Henri Mondor University Hospital, 94000 Creteil, France
    Med Mycol 43:S243-6. 2005
    ....
  5. ncbi request reprint Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study
    Catherine Cordonnier
    Hopital Henri Mondor, Creteil, France
    Int J Antimicrob Agents 31:135-41. 2008
    ..For AL, a 10mg/kg weekly dose appears to be well tolerated during chemotherapy and may represent an important tool towards improving AL patient outcome...
  6. ncbi request reprint [Early pneumonia after allogenic stem cell transplantation]
    C Cordonnier
    Service d Hematologie Clinique, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris et Université Paris 12, France
    Rev Mal Respir 24:523-34. 2007
    ..Pneumonia is one of the main causes of mortality following allogenic stem cell transplantation, especially in the first months after the transplant has been performed...
  7. ncbi request reprint Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis
    C Cordonnier
    Service d Hematologie Clinique, Hopital Henri Mondor, Creteil, France
    Mycoses 50:205-9. 2007
    ....
  8. ncbi request reprint A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipients
    Catherine Cordonnier
    Departement d Hematologie, Hopital Henri Mondor, Assistance Publique Hôpitaux de Paris AP HP and Université Paris 12, Creteil, France
    Transplantation 82:86-92. 2006
    ..The aim of this study was to determine the prognostic value of a grading system of infectious complications in predicting death...
  9. ncbi request reprint Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers
    Catherine Cordonnier
    Hopital Henri Mondor, AP HP and Université Paris 12, France
    Clin Infect Dis 42:955-63. 2006
    ..The goal of this retrospective and consecutive survey was to assess prognostic factors of death due to IA after HSCT at the time of diagnosis of IA...
  10. ncbi request reprint The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
    Catherine Cordonnier
    Hematology Department, CHU Henri Mondor, 94000 Creteil, France
    Haematologica 91:150a. 2006
  11. ncbi request reprint Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients
    C Cordonnier
    Department of Hematology, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Creteil, France
    Clin Infect Dis 38:1229-36. 2004
    ..Because of the increased numbers of unmatched donors and transplantation programs in countries with a high prevalence of tuberculosis, constant vigilance is required to early detect MBI in SCT recipients...
  12. ncbi request reprint Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
    C Cordonnier
    Hematology Department, Henri Mondor Hospital, Creteil, France
    Bone Marrow Transplant 33:943-8. 2004
    ..This small but homogeneous series indicates that voriconazole may be useful to prevent fungal relapse during at-risk periods in leukemic patients. Prospective trials are warranted to confirm these encouraging results...
  13. doi request reprint Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial
    Catherine Cordonnier
    Assistance Publique Hopitaux de Paris, Henri Mondor Teaching Hospital, Hematology Department, and Paris 12 University, 94010 Creteil, France
    Vaccine 28:2730-4. 2010
    ..One PPV23 dose after 3 PCV7 doses, already known to increase the response to PCV7, also extends the serotype coverage given 12 or 18 months after transplant...
  14. doi request reprint Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant
    C Cordonnier
    Department of Hematology, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris AP HP and Paris 12 University, Creteil, France
    Bone Marrow Transplant 45:1423-6. 2010
    ..We found a significant correlation between titers for both assays, and conclude that the response to PCV7 after SCT induces functional antibodies...
  15. ncbi request reprint Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy
    Catherine Cordonnier
    Hematology Department, University Paris XII, Henri Mondor Hospital, 94000 Creteil, France
    Clin Infect Dis 36:149-58. 2003
    ..Risk factors for staphylococcal and streptococcal infections differ among neutropenic patients. A simple scoring system for predicting streptococcal infection is proposed...
  16. doi request reprint Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation
    Catherine Cordonnier
    Hematology Department, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris AP HP and Paris 12 University, Creteil, France
    Clin Infect Dis 48:1392-401. 2009
    ..Our objective was to show that a 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar) was not inferior when first given 3 months after transplantation, compared with when first given 9 months after transplantation...
  17. ncbi request reprint Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
    Catherine Cordonnier
    Assistance Publique Hopitaux de Paris, Creteil, France
    Ann Intern Med 139:8-18. 2003
    ..Results of most trials were reported before effective drugs for cytomegalovirus infection and disease were available, and no trial was placebo controlled...
  18. doi request reprint Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
    Catherine Cordonnier
    Hematology Department, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris AP HP and Paris 12 University, Creteil, France
    Clin Infect Dis 48:1042-51. 2009
    ..Recent diagnostic improvements may ensure the early diagnosis of potentially invasive fungal disease. Reserving antifungals for this stage may achieve similar survival rates and reduce treatment toxicity and costs...
  19. doi request reprint Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
    C Cordonnier
    Haematology Department, Hopital Henri Mondor, AP HP, Creteil, France
    Clin Microbiol Infect 15:81-6. 2009
    ..This limitation calls for other microbiological tests, including analysis of bronchoalveolar lavage fluid, to establish a definitive diagnosis of IA...
  20. ncbi request reprint Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study
    Helene Esperou
    Hematology Department, St Louis Hospital, Assistance Publique Hopitaux de Paris AP HP, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    Transplantation 77:1854-8. 2004
    ..Allogeneic hematopoietic stem-cell transplantation is a widely used, cost-intensive procedure. Our purpose was to estimate costs and determine cost predictors...
  21. doi request reprint Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
    Alexandre Alanio
    Laboratoire de Parasitologie Mycologie, groupe hospitalier Chenevier Mondor, Assitance Publique Hôpitaux de Paris, Creteil, France
    J Antimicrob Chemother 66:371-4. 2011
    ..Our study aimed to estimate the prevalence of azole resistance in isolates prospectively collected in patients with haematological diseases...
  22. pmc Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro
    Francoise Botterel
    Universite Paris 12, Creteil, France
    BMC Microbiol 8:97. 2008
    ..Infection occurs by inhalation of airborne conidia, which are first encountered by airway epithelial cells. Internalization of these conidia into the epithelial cells could serve as a portal of entry for this pathogenic fungus...
  23. pmc Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study
    Caroline Even
    Assistance Publique Hopitaux de Paris AP HP, Groupe Hospitalier Henri Mondor Albert Chenevier, Hematology Department, Creteil, France
    Haematologica 96:337-41. 2011
    ..9, 95% CI 1.4-5.6, respectively). Patients with invasive fungal disease, even though they initially survive, undergo significant changes to their chemotherapy therapy. This impacts on the survival of patients with proven fungal disease...
  24. ncbi request reprint Applying the concept of healthcare-associated infections to hematology programs
    Sami Chehata
    Hematology Department, Henri Mondor Teaching Hospital, AP HP and Paris 12 University, Creteil, France
    Haematologica 91:1414-7. 2006
    ..Healthcare-associated infections should be preferred to nosocomial infections--which underestimates half of the healthcare-associated infections--as quality indicators for preventive programs...
  25. doi request reprint Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia
    Jean Marc Costa
    Laboratoire de Parasitologie Mycologie, Hôpital Henri Mondor AP HP, Creteil, France
    Clin Infect Dis 55:e5-8. 2012
    ..Both serum biomarkers are influenced by pulmonary fungal load, which should be taken into account when diagnosing Pneumocystis infection...
  26. ncbi request reprint Fungal infections: current diagnosis and treatment
    Catherine Cordonnier
    Henri Mondor Hospital, Creteil, France
    Hematol J 5:S59-62. 2004
  27. pmc Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients
    Francoise Botterel
    Laboratoire de Parasitologie Mycologie, groupe hospitalier Chenevier Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    J Clin Microbiol 50:227-31. 2012
    ..The relevant threshold remains to be determined and may vary according to the underlying disease...
  28. doi request reprint CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation
    Sebastien Maury
    Department of Hematology, Assistance Publique Hopitaux de Paris, Hopital Henri Mondor, Creteil F 94010, France
    Sci Transl Med 2:41ra52. 2010
    ..These findings offer a rational therapeutic approach for cancer cellular immunotherapy...
  29. doi request reprint Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease
    Florent Delbos
    Etablissement Français du Sang, Ile de France, HLA Laboratory, Creteil, France
    Biol Blood Marrow Transplant 22:292-9. 2016
    ..Donor immunization against foreign HLA antigens is a new parameter to predict the occurrence of GVHD after HSCT from HLA-mismatched unrelated donors. ..
  30. doi request reprint Primary in vitro culture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium and Aspergillus fumigatus interactions
    Khaled Khoufache
    UPEC, UMR BIPAR, ENVA, AFSSA, Creteil, France
    Med Mycol 48:1049-55. 2010
    ..PTEC behave similarly to human cells and are therefore a suitable alternative to human cells for studying interaction between airway epithelium and A. fumigatus...
  31. ncbi request reprint [Results of a survey on practices in onco-hematology in France in 2001]
    Catherine Cordonnier
    Service d Hematologie Clinique, Hopital Henri Mondor, Creteil
    Presse Med 33:324-6. 2004
    ..And this is the pivotal point of the external hospital treatment system...
  32. doi request reprint A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter
    Cecile Pautas
    APHP Henri Mondor, Hematology Department, F 94010, Creteil, France
    J Antimicrob Chemother 68:943-6. 2013
    ..We aimed to improve the microbial diagnosis of first episodes of febrile neutropenia (FEFNs) since <30% of episodes are microbiologically documented. Consequently patients are usually treated by empirical antibiotic therapy...
  33. doi request reprint Updated guidelines for managing fungal diseases in hematology patients
    Yosr Hicheri
    Hematology Department, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris and Paris 12 University, Creteil 94000, France
    Expert Rev Anti Infect Ther 8:1049-60. 2010
    ..This article summarizes these guidelines, which have very similar recommendations, and comments on their evidence base...
  34. doi request reprint Correlation Between Pneumocystis jirovecii Mitochondrial Genotypes and High and Low Fungal Loads Assessed by Single Nucleotide Primer Extension Assay and Quantitative Real-Time PCR
    Alexandre Alanio
    Laboratoire de Parasitologie Mycologie, AP HP, groupe hospitalier Saint Louis Lariboisière Fernand Widal, Paris, France
    J Eukaryot Microbiol 62:650-6. 2015
    ..Moreover, because microscopy detects only high fungal loads, the selection of microscopy-positive samples may miss genotypes associated with low loads...
  35. pmc Infections in myelodysplastic syndromes
    Andréa Toma
    Department of Hematology Henri Mondor University Hospital, 94000 Creteil, France
    Haematologica 97:1459-70. 2012
    ....
  36. ncbi request reprint PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma
    Lionel Karlin
    Department of Hematology, Hopital Henri Mondor, 94010 Creteil Cedex, France
    Haematologica 91:ECR54. 2006
  37. doi request reprint Donor regulatory T cells identified by FoxP3 expression but also by the membranous CD4+CD127low/neg phenotype influence graft-versus-tumor effect after donor lymphocyte infusion
    Yosr Hicheri
    AP HP, Groupe Henri Mondor Albert Chenevier, Service d Hematologie Clinique, Universite Paris 12, Paris, France
    J Immunother 31:806-11. 2008
    ....
  38. pmc Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant: A Comparative Series of 62 Patients
    Lisa Ghoufi
    From the Department of Dermatology, Assistance Publique Hopitaux de Paris AP HP, Groupe Hospitalier Henri Mondor Albert Chenevier, Creteil, France LG, SI HO, PW, OC Université Paris Est Créteil UPEC NO, CH, PW, CC, OC UMR S 955, Faculte de Medecine, Hopital Henri Mondor, Creteil, France NO Department of Pathology, AP HP, Groupe Hospitalier Henri Mondor Albert Chenevier, Creteil, France NO Department of Hematology, AP HP, Groupe Hospitalier Henri Mondor Albert Chenevier, Creteil, France WB, CP, FB, CR, CC, AT Department of Dermatology, centre hospitalier René Dubos, Pontoise, France EB and Lymphoid Malignancies Unit, AP HP, Groupe Hospitalier Henri Mondor Albert Chenevier, Creteil, Department of Physiology
    Medicine (Baltimore) 95:e3033. 2016
    ..A complete hematological assessment is mandatory at diagnosis, and monitoring blood cell counts should be recommended for at least 6 months after the diagnosis of H-SS...
  39. pmc Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards
    Hicham El Maaroufi
    Assistance Publique Hopitaux de Paris APHP, Haematology Department, Henri Mondor Hospital and Paris Est Créteil University, 94000 Creteil, France Haematology Department, hôpital militaire d instruction Mohamed V, Rabat, Morocco
    Biomed Res Int 2015:945769. 2015
    ..As the inappropriate administration of empirical antibacterial may alter survival, we studied risk factors for resistance to our usual empirical first-line antibacterial therapy, cefepime...
  40. pmc Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells
    Khaled Khoufache
    Laboratoire de Parasitologie Mycologie, Hôpital Henri Mondor AP HP, Universite Paris 12, and UMR BIPAR 956, Creteil, France
    BMC Microbiol 7:5. 2007
    ..In a previous study, we found that filtrates of A. fumigatus cultures can specifically alter the electrophysiological properties of human nasal epithelial cells (HNEC) compared to those of non pathogenic moulds...
  41. doi request reprint Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial
    Xavier Thomas
    Department of Hematology, Hopital Edouard Herriot, Lyon, France
    Leuk Res 36:1112-8. 2012
    ..We conclude that most adult patients with recurring AML could not be rescued using current available therapies, although allogeneic SCT remains the best therapeutic option at this stage of the disease...
  42. doi request reprint Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulair
    Florent Malard
    Hematology Department, Nantes Hospital and University Center CHU, Nantes, France INSERM UMR 938 and Pierre et Marie Curie University, Paris, France
    Biol Blood Marrow Transplant 21:1059-67. 2015
    ..These data suggest that in the setting of RIC/NMA, allo-SCT UCB is a valid alternative graft source, with significantly less chronic GVHD, compared with MisMUD, when there is no MUD available or when urgent transplantation is needed. ..
  43. pmc Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis
    Catherine Costa
    Laboratoire de Parasitologie Mycologie and UMR BIPAR 956, Hôpital H Mondor APHP, 94010 Creteil, France
    J Clin Microbiol 40:2224-7. 2002
    ..The LightCycler PCR assay, combined with automated DNA extraction, could be used in association with the GM assay to improve the reliability of IA diagnosis...
  44. doi request reprint Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients
    Catherine Cordonnier
    Department of Haematology, Henri Mondor Teaching Hospital, Assistance Publique Hopitaux de Paris, and Université Paris Est Créteil, Creteil, France
    J Antimicrob Chemother 71:2379-85. 2016
    ..This article focuses on the magnitude of the problem, the main differences in clinical presentation between haematology patients and other immunocompromised populations, especially HIV-infected patients, and the main risk factors. ..
  45. pmc Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study
    Catherine Cordonnier
    Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, and Université Paris Est Créteil, France
    Clin Infect Dis 61:313-23. 2015
    ..Life-threatening Streptococcus pneumoniae infections often occur after hematopoietic stem cell transplant (HSCT); vaccination is important for prevention...
  46. doi request reprint Immunization in cancer patients: where we stand
    Christine Robin
    Hematology Department, Henri Mondor Teaching Hospital, Assistance Publique Hopitaux de Paris AP HP, France Paris Est Créteil University UPEC, 94000 Creteil, France
    Pharmacol Res 92:23-30. 2015
    ..Although many questions remain to be clarified, oncologists and hematologists should be encouraged to implement these guidelines in their therapeutic programs and to develop prospective studies covering unsolved issues. ..
  47. doi request reprint Mucormycosis: a new concern in the transplant ward?
    Christine Robin
    aHematology Department, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris AP HP bParis Est Créteil University UPEC, Créteil cParasitology Mycology Laboratory, Groupe hospitalier Lariboisière Saint Louis Fernand Widal dUniversité Paris Diderot, Sorbonne Paris Cité eInstitut Pasteur, Unité de Mycologie Moléculaire, CNRS URA3012, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France
    Curr Opin Hematol 21:482-90. 2014
    ..This study focuses on the epidemiology and management of mucormycosis in hematopoietic stem cell transplant patients, a life-threatening mold infection whose incidence has increased over the past decades...
  48. doi request reprint Pneumococcal immunization in immunocompromised hosts: where do we stand?
    Catherine Cordonnier
    Hematology Department, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris AP HP and Université Paris Est Créteil, Creteil 94000, France
    Expert Rev Vaccines 13:59-74. 2014
    ..We review here the efficacy and safety of the different antipneumococcal vaccines in cancer, transplant and HIV-positive patients and propose a critical appraisal of the current guidelines. ..
  49. ncbi request reprint Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia
    Vincent Cattoir
    Laboratoire de bactériologie virologie hygiène, CHU Henri Mondor, Assistance Publique Hopitaux de Paris, Universite Paris XII, Creteil, France
    J Antimicrob Chemother 59:1010-2. 2007
    ....
  50. ncbi request reprint Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
    Pierre Reusser
    Medizinische Klinik A, University Hospital, Basel, Switzerland
    Blood 99:1159-64. 2002
    ....
  51. doi request reprint Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
    Olivier Lortholary
    Universite Paris Descartes, Department of Infectious and Tropical Diseases, Centre d Infectiologie Necker Pasteur, Hopital Necker Enfants Malades, Paris, France
    Lancet Infect Dis 8:612-20. 2008
    ....
  52. ncbi request reprint Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey
    Dan Engelhard
    Department of Pediatrics, Hadassah University Hospital and Hebrew University Hadassah Medical School, Ein Karem, Jerusalem, Israel
    Br J Haematol 117:444-50. 2002
    ..The high IPI mortality rate, both early and late post-transplantation, requires preventive approaches, mainly effective immunization...
  53. ncbi request reprint Toxoplasmosis following allogeneic hematopoietic stem cell transplantation
    Rodrigo Martino
    Bone Marrow Transplant 31:617-8; author reply 619. 2003
  54. ncbi request reprint Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis
    Per Ljungman
    Department of Hematology, Huddinge University Hospital, SE 14186 Stockholm, Sweden
    Blood 102:4255-60. 2003
    ..Our data suggest that donor CMV status influences outcome of unrelated SCT. For a CMV-seropositive patient, a seropositive donor might be preferable...
  55. ncbi request reprint Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood a
    Olle Ringden
    Centre for Allogeneic Stem Cell Transplantation, Division of Clinical Immunology F79, Karolinska Institute, Huddinge University Hospital, SE 141 86 Stockholm, Sweden
    J Clin Oncol 22:416-23. 2004
    ..Granulocyte colony-stimulating factor (G-CSF) is given after bone marrow transplantation (BMT) to shorten the neutropenic phase. Its effects have not been evaluated in a large patient population...
  56. ncbi request reprint Sepsis associated with immunosuppressive medications: an evidence-based review
    Juan C Gea-Banacloche
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 32:S578-90. 2004
    ....
  57. pmc Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B
    Fritz Offner
    UZ Gent, Ghent, Belgium
    Antimicrob Agents Chemother 48:4808-12. 2004
    ..3%) patients, and hypokalemia was seen for 13 (39.4%). We conclude that liposomal nystatin can be effective for salvage therapy of invasive aspergillosis. Infusion-related adverse events have been observed frequently...
  58. ncbi request reprint Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
    Ute Hegenbart
    University of Leipzig, Leipzig, Germany
    J Clin Oncol 24:444-53. 2006
    ....
  59. pmc Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the Euro
    Rodrigo Martino
    Hematology Department of Sant Pau Hospital, Autonomous University of Barcelona, Spain
    Blood 108:2928-36. 2006
    ..001]). These findings may help in the interpretation and design of future studies on secondary prophylaxis of IA after an allo-HSCT...
  60. ncbi request reprint Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
    Johan Maertens
    Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium
    Cancer 107:2888-97. 2006
    ..Interest remains as to whether caspofungin, in combination with other antifungal classes, can improve the efficacy against IA...
  61. ncbi request reprint Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia
    Ramzi Ben Amor
    Transplantation 84:1066-7. 2007
  62. ncbi request reprint Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation
    Rodrigo Martino
    Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain
    Clin Infect Dis 40:67-78. 2005
    ..Isolated case reports have shown that recipients of allogeneic hematopoietic stem cell transplants (HSCTs) who develop toxoplasmosis may have circulating Toxoplasma gondii DNA in peripheral blood before the onset of clinical symptoms...
  63. ncbi request reprint Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Clin Infect Dis 43:1031-9. 2006
  64. ncbi request reprint Prevention of nosocomial fungal infection: the French approach
    Jean Pierre Gangneux
    Clin Infect Dis 35:343-6. 2002